Telix Pharmaceuticals Stock Target Price and Analyst Consensus
| TLX Stock | 7.47 0.11 1.45% |
The current analyst and expert consensus on Telix Pharmaceuticals is Strong Buy, with 2 strong buy opinions. The current projected Telix Pharmaceuticals target price consensus is 20.90 with 2 analyst opinions. Check out Macroaxis Advice on Telix Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Telix Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Telix Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Telix Pharmaceuticals. We encourage you to use your own analysis of Telix Pharmaceuticals to validate this buy or sell advice. Telix Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Telix Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 2.7568.
Lowest Forecast 19.01 | Highest Forecast 23.19 | Target Price 20.9 |
It's important to approach Telix Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Telix Pharmaceuticals Target Price Consensus
Telix target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Telix Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 2 | Strong Buy |
Most Telix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Telix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Telix Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationTelix Pharmaceuticals Target Price Projection
Telix Pharmaceuticals' current and average target prices are 7.47 and 20.89, respectively. The current price of Telix Pharmaceuticals is the price at which Telix Pharmaceuticals Limited is currently trading. On the other hand, Telix Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Telix Pharmaceuticals Market Quote on 6th of January 2026
Target Price
Analyst Consensus On Telix Pharmaceuticals Target Price
Telix Pharmaceuticals Analyst Ratings
Telix Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Telix Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Telix Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Telix Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Telix Pharmaceuticals price targets
Telix Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Telix Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Telix Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Telix Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Telix Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Telix Pharmaceuticals is a key component of Telix Pharmaceuticals valuation and have some predictive power on the future returns of a Telix Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Robots And Drones Invested few shares | |
 | Giant Impact Invested over 60 shares | |
 | Macroaxis Index Invested one share | |
 | Buywrite ETFs Invested over 300 shares | |
 | IT Invested over 100 shares | |
 | Momentum Invested one share | |
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.